Characterization of Dermal Fibroblasts as a Cell Source for Pediatric Tissue Engineered Heart Valves
There is continued debate regarding the appropriate cell type to replace valvular interstitial cells (VICs) in tissue engineered heart valves (TEHVs), particularly for pediatric patients. In this work, neonatal human dermal fibroblasts (nhDFFs) were compared to human pediatric VICs (hpVICs), based o...
Main Authors: | Monica M. Fahrenholtz, Huiwen Liu, Debra L. Kearney, Lalita Wadhwa, Charles D. Fraser, K. Jane Grande-Allen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-08-01
|
Series: | Journal of Cardiovascular Development and Disease |
Subjects: | |
Online Access: | http://www.mdpi.com/2308-3425/1/2/146 |
Similar Items
-
Shear Stress Quantification in Tissue Engineering Bioreactor Heart Valves: A Computational Approach
by: Raj Dave, et al.
Published: (2024-03-01) -
Interactive contribution of hyperinsulinemia, hyperglycemia, and mammalian target of rapamycin signaling to valvular interstitial cell differentiation and matrix remodeling
by: Jessica I. Selig, et al.
Published: (2022-10-01) -
Heart Valve Disease: Challenges and New Opportunities
by: Francesca Bartoli-Leonard, et al.
Published: (2020-10-01) -
Radiation Induces Valvular Interstitial Cell Calcific Response in an in vitro Model of Calcific Aortic Valve Disease
by: Manon Meerman, et al.
Published: (2021-08-01) -
Sustainable varicose vein therapy using functionalized hydrogels derived solely from livestock waste
by: Peter R. Corridon, et al.
Published: (2024-08-01)